Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively and safely treats male hair loss for over a year.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Some off-label treatments increase hair density, but long-term safety unknown.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

UVB is good for a skin condition in Asian kids, a lotion works for head lice, a drug helps with a skin blistering disorder, a foam reduces itchiness in skin inflammation, birthmarks can be more widespread, and criteria for a neurocutaneous disorder were agreed upon.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

PRP is an effective and safe treatment for female hair loss.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Experts met to improve care for ichthyosis patients in Spain.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

The model and estimator can predict drug exposure in kidney transplant patients well.